GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Advik Laboratories Ltd

Advik Laboratories Board to Consider Q2 FY27 Un-Audited Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 03 Nov 2026, 06:16 PM IST  ·  BSE ID: 8c85c58b-3463-4102-b0b3-5b967461905f
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on November 13, 2026, to review its financial performance for July-September 2026.
🤖 AI Summary
  • Advik Laboratories Ltd Board meeting scheduled for November 13, 2026.
  • Purpose is to consider and approve un-audited financial results for Q2 FY27.
  • Results cover the quarter and half year ended September 30, 2026.
  • Trading window for designated employees closed until November 15, 2026.
  • Company is formerly Advik Laboratories Limited, now MPS Pharmaa Limited.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected as this announcement precedes the release of the company's Q2 FY27 financial performance.
🔍
Management Signal
Management is adhering to regulatory requirements by scheduling the board meeting to approve and release the quarterly financial results.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome on November 13, 2026 — for Q2 FY27 financial results.
Release of un-audited financial results for Q2 FY27.
Review of the Limited Review Report for Q2 FY27.
LOW RISK This filing is a standard procedural announcement for a board meeting.
💡 Investor Takeaway
Advik Laboratories Ltd (now MPS Pharmaa Limited) has announced a Board meeting on November 13, 2026, to approve the un-audited financial results for the quarter and half year ended September 30, 2026 (Q2 FY27). No financial figures are available in this filing.
❓ Frequently Asked Questions
When is the Advik Laboratories Ltd Board meeting scheduled?
The Board of Directors of Advik Laboratories Ltd (now MPS Pharmaa Limited) is scheduled to meet on Friday, November 13, 2026, at 03:00 P.M.
What is the purpose of the Advik Laboratories Ltd Board meeting on November 13, 2026?
The meeting is being held to consider and approve the Un-Audited Financial Results for the quarter and half year ended September 30, 2026, along with the Limited Review Report thereon.
For which period will Advik Laboratories Ltd's financial results be approved?
The Board will approve the un-audited financial results for the quarter and half year ended September 30, 2026, which corresponds to Q2 FY27.
When does the trading window for Advik Laboratories Ltd close?
The trading window for dealing in Advik Laboratories Ltd shares for designated persons is closed and will remain closed until November 15, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.